Kyle is a medical oncologist who started his career focusing on GI tumors at the University of Wisconsin Carbone Cancer Center. In 2009, he began working at AbbVie as a medical director, later as project leader, for a variety of oncology and hematology assets. His current role is the Head of AbbVie's Development Design Center, an initiative to create innovation and excellence in clinical design and execution across AbbVie's entire portfolio of novel medications.